The global automated cannabis testing demand is anticipated to grow at a prolific CAGR of around 11% to 13% during the forecast period from 2022 to 2032. Growth in the market is attributable to the rising adoption of automation in cannabis testing laboratories and increasing demand for high quality cannabis based medical products across the world.
Report Attribute | Details |
---|---|
Automated Cannabis Testing Market Projected Growth Rate (2022 to 2032) | 11% to 13% CAGR |
Despite stringent regulations and risk of drug addiction, demand for cannabis has witnessed significant increase over the last few years due to its various medicinal properties. Cannabis, also known as marijuana, is a psychotic drug derived from the genus of cannabaceae family.
Medical cannabis is still in its introductory phase in the medical health industry. Various researches have revealed the potential of cannabis in treating a number of health conditions such as chronic pain, muscle spasm, insomnia, diabetes, vomiting and several mental disorders. However, cannabis testing is required before cannabis products can be used for various applications as well as to uncover various promising properties of cannabis.
Today, most of the research and development laboratories have resorted to automation. Automated cannabis testing is an innovative process of evaluating the safety, potency and quality of cannabis products using advanced equipment. Rising demand for quality medical marijuana products across the world is a major factor driving the automated cannabis testing market.
Cannabis contains over 100 compounds (called cannabinoids), which trigger psychoactive effects after consumption. Automated cannabis testing is done to ensure that harmful chemicals do not find their way into the products as well as to improve the quality of products.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Growing demand for high quality medicinal cannabis products, legalization of marijuana across various regions, growing penetration of modern technologies across cannabis testing laboratories, and increase in the number of research and development laboratories are some of the major factors driving the global automated cannabis testing market.
Automation of laboratory workflow has become a need of the hour in the modern world. To follow this trend, laboratories associated with cannabis testing are also integrating modern technologies to improve results, minimize human interference, and reduce processing time. Rising adoption of automation for cannabis testing is providing a major impetus to the growth of automated cannabis testing,
Automated cannabis testing is used to determine the levels of cannabinoid, terpenes, pesticides, heavy metals, moisture content etc. in quick time and with better accuracy. As the trend of using high quality medicinal cannabis products grows, more and more cannabis testing laboratories are resorting towards automation. This will continue to provide tailwinds to the growth of automated cannabis testing market during the forecast period.
Similarly, rising government legalizations on the distribution and consumption of medical marijuana is emerging as another factor boosting the growth of automated cannabis testing market. Various states are monitoring and legalizing marijuana for medicinal and recreational purposes. For instance, in 2021 4 states (New York, New Mexico, Connecticut, and Virginia) passed legislation to legalize marijuana for recreational purposes.
In addition to this, growing awareness among people regarding the benefits of cannabis in pain management and other medicinal purposes will further create growth prospects within the global automated cannabis testing market in future.
Despite positive growth projections, the global automated cannabis testing market is facing various challenges that are restraining its growth to a large extent. Some of these challenges are the presence of stringent regulations, lack of standardization, and high cost of automated cannabis testing equipment.
Most nations of the world have strict regulations on the use of cannabis, which is becoming a major hurdle for the growth of automated cannabis testing market.
North America was the largest market for automated cannabis testing in 2022 and is expected to continue its dominance during the forecast period, owing to the increasing spending on research activities, growing popularity of cannabis for pain management application, heavy presence of leading market players, and legalization of cannabis across some areas.
Over the last few years, various legislations have been passed in nations like the United States and Canada to legalize cannabis for recreational purposes. This has significantly increased the demand for high quality marijuana products. Driven by this, these countries are slated to witness rapid growth of automated cannabis testing market during the forecast period.
Moreover, increasing research and development activities for exploring the potential benefits of cannabis along with a rise in number of cannabis testing laboratories and growing penetration of automation will further generate growth avenues within the automated cannabis testing market in future.
According to Future Market Insights, Europe is expected to provide immense growth opportunities for automated cannabis testing market players during the forecast period, owing to the increasing consumption of medicinal cannabis, rising penetration of lab automation for improving results and saving time, and increase in product approvals by regulating bodies.
Countries like Malta and Germany are becoming lucrative destinations for automated cannabis testing due to legalization of marijuana and growing consumer demand for high quality products.
Similarly, growing adoption of automation by cannabis testing laboratories across these European nations is boosting the growth of automated cannabis testing market and the trend is likely to continue in future.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the key participants present in the global automated cannabis testing market include Medicinal Genomics Corp., PerkinElmer Inc., Agilent Technologies, Inc., Todaro robotics, Hamilton Company, Quantum Analytics, Shimadzu Scientific Instruments, among others.
These key players are continuously focusing on new product launches and approvals to gain a competitive edge in the market. Furthermore, they have adopted various organic and inorganic growth strategies to expand their global footprint.
Report Attribute | Details |
---|---|
Growth Rate | CAGR of 11% to 13% from 2022 to 2032 |
Base Year for Estimation | 2021 |
Historical Data | 2015 to 2020 |
Forecast Period | 2022 to 2032 |
Quantitative Units | Revenue in USD Billion and CAGR from 2022 to 2032 |
Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
Segments Covered | Product Type, Application, End User, Region |
Regions Covered | North America; Latin America; Western Europe; Eastern Europe; APEJ; Japan; Middle East and Africa |
Key Countries Profiled | USA, Canada, Brazil, Argentina, Germany, UK, France, Spain, Italy, Nordics, BENELUX, Australia & New Zealand, China, India, ASEAN, GCC, South Africa |
Key Companies Profiled | Medicinal Genomics Corp.; PerkinElmer Inc.; Agilent Technologies, Inc.; Todaro robotics; Hamilton Company; Quantum Analytics; Shimadzu Scientific Instruments |
Customization | Available Upon Request |
FMI projects the global automated cannabis testing market to expand at around 11% to 13% value CAGR by 2032
As per FMI, North America and Europe will continue to remain the most attractive markets for automated cannabis testing over the assessment period.
Medicinal Genomics Corp., PerkinElmer Inc., Agilent Technologies, Inc., Todaro robotics, and Hamilton Company are some prominent automated cannabis testing manufacturers
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Automated Cannabis Testing Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 5. Global Automated Cannabis Testing Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type 5.1. Stand Alone Cannabis Testing Devices 5.2. Portable Cannabis Testing Devices 5.2.1. Table-Top Analyzers 5.2.2. Hand-held Analyzers 6. Global Automated Cannabis Testing Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Technology 6.1. HPLC 6.2. LCMS 6.3. ICP-MS 6.4. ICP-OES 6.5. Gas Chromatography Mass Spectrometry 6.6. Others 7. Global Automated Cannabis Testing Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User 7.1. Pharmaceutical Companies 7.2. Agriculture Laboratory 7.3. Cannabis Testing Facilities 7.4. Academic Institutes 7.5. Cannabis Research Centres 7.6. Others 8. Global Automated Cannabis Testing Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 8.1. North America 8.2. Latin America 8.3. Europe 8.4. East Asia 8.5. South Asia & Pacific 8.6. MEA 9. North America Automated Cannabis Testing Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 10. Latin America Automated Cannabis Testing Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 11. Europe Automated Cannabis Testing Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12. East Asia Automated Cannabis Testing Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 13. South Asia & Pacific Automated Cannabis Testing Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 14. MEA Automated Cannabis Testing Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 15. Key Countries Automated Cannabis Testing Market Analysis 16. Market Structure Analysis 17. Competition Analysis 17.1. Perkin Elmer, Inc. 17.2. Shimadzu Corporation 17.3. Merck KGaA 17.4. Agilent Technologies, Inc. 17.5. AB SCIEX LLC 17.6. Cannabix Technologies, Inc. 17.7. Waters Corporation 17.8. Steep Hill Labs, Inc. 17.9. Digipath Labs, Inc. 17.10. Medicinal Genomics Corp. 17.11. Hamilton Company 17.12. LabX 17.13. Todaro Robotics 17.14. Promium, LLC. 17.15. Thermo Fisher Scientific 17.16. Neu-tec Group Inc. 17.17. QUANTUM ANALYTICS 17.18. VWR (Avantor) 17.19. MyDx, Inc 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports